I truly hope Gilead’s Remdesivir is wildly successful in treating COVID-19, but from an investor standpoint it’s truly underperformed peers over the last 5 years. $gild $amgn $abbv $abt $mrk $jnj  $xbi #chart https://t.co/VEk1LMLMLo